Location History:
- 75005 Paris, FR (2001 - 2002)
- Paris 75005, FR (2003)
- Boulogne sur Mer, FR (2023)
- Paris, FR (1997 - 2024)
Company Filing History:
14 out of 20 
4 out of 5 
1 out of 1 Years Active: 1997-2025
Title: Innovations and Contributions of Jean-Baptiste Drevet in Medical Technology
Introduction: Jean-Baptiste Drevet is a prominent inventor based in Paris, France, known for his remarkable contributions to the field of medical technology. With an impressive track record of 22 patents, Drevet has significantly advanced the development of implantable devices that enhance patient care and treatment options.
Latest Patents: Among his latest innovations, Drevet has developed an "Implantable pump system having an undulating membrane with improved hydraulic performance." This implantable pump system, suitable for use as a left ventricular assist device (LVAD), boasts a unique design featuring a flexible membrane attached to an actuator assembly. The system utilizes electromagnetic coils to create wavelike undulations, effectively propelling blood throughout the device. The controller is designed to operate in a manner that mimics physiological flow rates, thus avoiding complications such as thrombus formation and platelet activation. Another significant patent by Drevet is the "Implantable pump system having an undulating membrane," which incorporates both an extracorporeal battery and a controller to optimize the pump's functionality while ensuring efficient blood propulsion.
Career Highlights: Throughout his career, Jean-Baptiste Drevet has made lasting impacts in the medical device industry. His work primarily centers around enhancing cardiovascular technologies, particularly through innovations that improve the performance of left ventricular assist devices. His impressive portfolio of patents reflects his dedication to finding solutions that improve healthcare delivery.
Collaborations: Drevet’s innovative journey has been enriched by collaborations with esteemed professionals in the field. Notable coworkers such as Carl N Botterbusch and Silvere Lucquin have shared insights and expertise, contributing to the success of various projects Drevet has undertaken. These collaborations have fostered a creative environment where groundbreaking ideas can flourish.
Conclusion: Jean-Baptiste Drevet's impressive body of work and his 22 patents demonstrate his commitment to advancing medical technology. His innovations in implantable pump systems have the potential to transform patient experiences in cardiovascular care. As he continues to innovate, the impact of his contributions is sure to be felt in the healthcare sector for years to come.